Biotechnology Research in Hong Kong

Gene Company Limited

Join us in taking Baygene global! We're seeking ambitious distributors worldwide for our cutting-edge biotech products. Ready to partner? Contact us today!(Note: We only distribute Baygene outside Hong Kong and Mainland China.) Our scope of business can be categorized into two main areas:(a) the distribution of full range molecular and cell biology instrumentation, reagents, and consumables and (b) the consultation services on research projects and experimental techniques. Since the establishment of Gene, we have successfully acquired exclusive distributorships in China and Hong Kong from a number of world-class manufacturers.

51 to 200 staff

Hong Kong Labware

Since our founding in 2002, Labware Group has been a pioneer in Laboratory industry in Hong Kong, Macau and South China. From the development of consumable business to the introduction of "One Stop Shop" concept, Labware group has taken a leadership position to contribute to the substantial growth of the industry. Whenever our clients think of laboratory solution, they would think about us.

51 to 200 staff

Hong Kong Life Sciences Society Hklss

The Hong Kong Life Sciences Society (HKLSS) is an organization dedicated to fostering a vibrant life sciences ecosystem in Hong Kong. Founded in 2018 by Nan Fung Group, HKLSS is at the forefront of nurturing and attracting young talent from around the globe. By providing a platform for knowledge exchange, industry partnerships, and public engagement, we play a pivotal role in enhancing Hong Kong's position as a hub for life sciences.

201 to 500 staff

Wecare Probiotics Co., Ltd

Wecare Probiotics pioneers probiotic innovation through 30 years of scientific excellence. Achieving the market position as the No.1 in Production Capacity in Asia and the No.1 in Global Sales among Asian Probiotic Raw Material Enterprises, we supply over 2,200 tons annually from four intelligent manufacturing bases, and meet stringent international certifications. Wecare Probiotics Research Institute drives innovation from discovery to clinical validation and intelligent large-scale manufacturing, developing solutions for supplements, food, health, and animal nutrition. Trusted in over 80 countries, we are committed to becoming a world-class probiotic partner through integrity, innovation, and collaboration.

501 to 1000 staff

Geneharbor

Info of anti-aging product NMN and GeneHarbor's other products of enzymatic production technologies.

51 to 200 staff

Hkbio

HKBIO is an independent non-profit organization with the goal to promote best practice, raise awareness across the biotechnology industry while providing added value benefits to its members, whether they are students, researchers, entrepreneurs, industry bodies, public or private sector representatives. THE HKBIO VISION "Hong Kong Biotechnology Organization’s vision is to be the recognized peak industry body representing Hong Kong and China’s Biotechnology Industry by effectively fostering leadership, partnership networks and knowledge growth, bringing benefits of Biotechnology to the local and global community." HKBIO will achieve this vision by representing members across all areas related to biotechnology and its devotion to establishing and facilitating a worldwide platform for the Hong Kong biotech industry, promoting awareness, encouraging and enabling international collaboration and providing informed opinion and technical advice to government bodies, healthcare institutions and the general public. THE HKBIO MISSION Our mission statement is:"To develop, cultivate and promote the professional and institutional disciplines of biotechnology in Hong Kong and China for the benefit of members, the public and the global community." We will achieve our mission by developing and maintaining relationships with experienced and knowledgeable practitioners from the biotechnology and pharmaceutical industries worldwide; administering and overseeing education training programs, seminars and conferences in Hong Kong SAR and China, the advancement and dissemination of biotech knowledge; creating a membership forum, leveraging core expertise in providing collaborative solutions to the development of leading-edge products and services in all fields related to biotechnology. It is with this dedication that HKBIO is committed to being the lifelong resource to the whole of biotechnology community in Hong Kong and China.

201 to 500 staff

Aurora Scientific

For over thirty years Aurora Scientific measurement instrumentation has been the choice of leading science researchers around the world. Our selection of dual mode lever systems and force transducers are used in a broad array of life science research specialties including exercise and metabolism, cardiology, injury recovery, gerontology, disease progression and pharmacology, and more. Our fast response sensors are considered benchmark instruments in olfaction research studying odor dynamics and pheromone/plume dispersion, and our mechanical stimulator technology is used in studies of the neuronal response to touch, pain and stretch. Many instruments have also been adapted for use by material science researchers studying the properties of artificial muscle, locomotion and nanomaterials. Legacy instruments used in the field of environmental monitoring and mine operations are still in use today. Aurora Scientific is committed to creating products that answer questions and solve problems. We value excellence, innovation, responsiveness and the satisfaction of a job well done. And we share the researcher’s desire to broaden the boundaries of knowledge and understanding.

11 to 50 staff

Haplox Global

HaploX is a leading provider of genetic testing solutions, specializing in gene sequencing, liquid biopsies, bioinformatics, and big data analytics. Driven by a passion for technological innovation, we aim to harness advanced science for the betterment of humanity. Our commitment is to establish ourselves as a preeminent life sciences company globally. Our laboratory adheres to stringent international best practice guidelines and is accredited by recognized bodies including the College of American Pathologists (CAP), the Clinical Laboratory Improvement Amendments (CLIA), and the European Molecular Genetics Quality Network (EMQN). This ensures the highest standards of quality and reliability in our testing processes. HaploX offers a comprehensive range of services encompassing clinical genetic testing, non-clinical testing solutions, and pharmaceutical drugs R&D. We serve a diverse clientele, including hospitals, biopharmaceutical entities, scientific research institutions, and healthcare organizations, reflecting our global outreach and trusted expertise in the field.

501 to 1000 staff

Forest Hills Lab

Forest Hills Lab (FHL) is an innovative global life sciences company focused on regeneration and committed to improving well-being in our rapidly aging society. FHL is composed of two divisions: the Therapeutics division and the Aesthetics division. FHL Therapeutics division is a clinical-stage, therapeutic drug development platform focused on neurodegenerative diseases with high unmet need. FHL Aesthetics division develops and markets a comprehensive line of aesthetics products globally. Our global network spans offices in the United States, Singapore, South Korea and Hong Kong, where we are headquartered.

51 to 200 staff

Hsk Genetech Probiolife

HSK GeneTech Limited is founded by Professor Kwan Hoi Shan from the Chinese University of Hong Kong and a team of PhD scientists. Professor and the team have had more than 40 years of experience in DNA sequencing and researches in food. Over 10 years of experience in working with the University in research projects and NGS sequencing services. The vision of the company is to improve the well-being and health of the general public, by providing affordable products and services with latest science findings. ProbioLife Limited is a brand of HSK GeneTech to promote colon's health and the importance of it. With health supplement products aim to improve colon and digestive health for a healthy lifestyle. The company had been successfully granted by various funds- Hong Kong Science and Technology Park 'Bio-Incubation Program' Funding - Two consecutive years of receiving The Chinese University of Hong Kong Technology Startup Support Scheme Funding, in 2014-15 and 2016-17

1 to 10 staff

Iconthin Biotech

Iconthin Biotech, a specialist in Algae-Based Ingredients, is dedicated to pioneering sustainable biotechnology. Our focus extends from enterprise services to the development of consumer-facing products, including nutraceuticals, skincare, and functional foods. At the core of our cutting-edge technology is our commitment to innovation, underscored by our partnership with the renowned microalgae research team at the University of Toronto. We proudly introduce AlgaeAsta™ - Leading with Natural Astaxanthin. Discover the power of AlgaeAsta™ Astaxanthin, derived 100% from the microalgae Haematococcus pluvialis using the latest 3rd generation cultivation technology. Our natural astaxanthin outperforms its synthetic counterpart in terms of efficacy and safety, making it the right choice for health-conscious consumers. Join us in our journey to drive sustainable biotechnology and experience the benefits of AlgaeAsta™.

11 to 50 staff

Mirxes Hong Kong

Mirxes 45MiRXES : mirxes.com/ Whatsapp : https://bit.ly/GCfLI Facebook: facebook.com/mirxes.hkInstagram: instagram.com/mirxes.hk

201 to 500 staff

Beth Bioinformatics Co., Ltd

Beth Bioinformatics (BethBio) is a biotech company that develops state-of-the-art technologies to empower the development of new and better vaccines. Utilizing virology, AI and computational biology, BethBio provides a series of innovating bioinformatics solutions to pharmaceutical companies, including virus evolution prediction for SARS-CoV-2 and Influenza, real-time vaccine effectiveness (VE) evaluation, codon (de)optimization, epitope screening, antigen design and more. These solutions could help our clients solve various technical difficulties such as protein expression, improve efficacy or manufacture efficiency of their products, and identify potent epitopes for candidates such as broadly-reactive T-cell or cancer vaccines. In addition, the company also develops accurate and robust human genome interpretation technologies for improved human disease prediction, that could be applied to multi-population data and achieve true-individualized prediction. The company is working closely with pharmaceutical and genetic-testing companies, including several new vaccine co-development projects.

1 to 10 staff

Act Genomics Hk Ltd

ACT Genomics is an innovation –driven cancer solution provider in Asia with offices in Taipei, Singapore, Hong Kong & Tokyo. With our Next-Generation Sequencing (NGS) technology and experienced bioinformatics team, we provide optimal cancer treatment planning, cancer relapse and drug resistance monitoring, cancer risk assessment and immunotherapy evaluation to medical professionals. Our team is specialized in biomarker identification, underlying disease mechanism discovery and genetic alteration exploration for academia around the world. Pharmaceutical communities also benefit from our expertise in identifying targets for drug development, stratifying patients for clinical studies and delineating drug responses with efficiency and efficacy. We ‘turn genomics into action’.

201 to 500 staff

Immuno Cure

Immuno Cure is a clinical stage biotechnology group based in the Hong Kong Science Park, focusing on research and development of innovative DNA medicines and antibody immunotherapies to fight against cancers, inflammatory and infectious diseases based on its patented PD-1-enhanced DNA Vaccine, Anti-Δ42PD1 Antibody; and Vaccine Delivery platforms.

51 to 200 staff

Pec Engineering Limited

PEC ENGINEERING LIMITED is a Plumbing & Drainage and Automatic Irrigation System Specialist in Hong Hong.

11 to 50 staff

Wing Wah Food Manufactory Limited

11 to 50 staff

Arctic Vision Ltd

Arctic Vision is a China-based ophthalmic biotech focusing on breakthrough therapies, with a leading portfolio covering pre-clinical stage to commercial stage products. Based in China with global ambitions, we are committed to harnessing deep end-user insights and unlocking ophthalmic innovations to bring eye products and therapies that solves unmet clinical needs and benefit patients and consumers. Arctic Vision is led by an elite team of ophthalmic industry veterans with proven domestic and global track record in the successful research and development, and commercialization of eye care products. We are backed by recognized life science investors and biotechnology venture capital with broad networks in China, Asia, United States and Europe ophthalmic markets, in-depth industry knowledge and longstanding experience in business incubation. We work as trusted partners to global biopharmaceutical companies looking to access the Chinese market and drive long-term strategic clinical development and growth. Arctic Vision is driven by our dual-engine growth strategy, cutting-edge technology and consumer-oriented technology, which marrying advances in bioscience and technology, with real-time market needs and demand, to bring ophthalmology innovations that are truly meaningful and game changing. Across the business, we constantly push the boundaries of exploration and innovation to get higher and further in the quest to improving vision for mankind. Our goal is for people to see clearer, live better. At Arctic Vision, that is our promise, and our motivation.

51 to 200 staff

Gerald Choa Neuroscience Institute

The GCNI aspires to become a highly interactive and productive research group at CUHK. With the common goal of advancing fundamental neuroscience knowledge, GCNI will strengthen and expand the CUHK neuroscience community, and will accelerate the discovery of important new knowledge about the nervous system.

11 to 50 staff

Hk-Dtech

HK-Dtech is a young company dedicated to the research and development (R&D) of fluorescent nanomolecules in the field of health and life sciences. Created by experts in chemistry and detection, HK-Dtech aims to become a platform, a pioneer and leader in markers related technical of analysis and imaging. The company’s vision is to improve screening and early detection of diseases to increase treatment success and eliminate side effects for the patients. Our goal is to exceed the current technical limits by designing, producing and marketing fluorescent nanomolecules with unique features to improve the detection of various biomarkers in the service of the scientific research and the medical diagnosis (In Vitro Diagnosis – IVD)

1 to 10 staff

Molbreeding Biotech

Founded in April 2017, Molbreeding is a leading biotech company that specializes in genotyping and breeding technology innovation. We have established a robust global presence with sample collection centers in EMEA, Asia, and America. Our proprietary technology, genotyping by targeted sequencing (GBTS), enhances detection accuracy, reduces testing costs and time, and significantly improves the efficiency of molecular breeding in both plants and animals. At Molbreeding, we have developed over 600 marker panels across more than 180 species and have genotyped over 2 million samples. Our extensive research efforts have resulted in hundreds of publications, showcasing our commitment to advancing the field of molecular breeding.

201 to 500 staff

B.Y. Quantitative Medicine Limited

We are the first company to establish a quantitative biochemistry platform for the analysis of genes interaction. Our self-developed deep learning service model provides a comprehensive and structural strategy to determine the gene co-expression network of cancers and other diseases related to Nucleophosmin (NPM1/B23). This model provides important data for health assessment, disease diagnosis, prognosis, and treatment, and for related drug development. Our focus has been on cancer-related research and we have successfully obtained important quantitative medical data such as ovarian cancer, breast cancer, pancreatic cancer, liver cancer (viral infection), colorectal cancer, lung cancer and other related cancer recurrence prediction, cancer stage assessment, chemoresistance, metastasis, and distinguishing low-risk and high-risk patients etc.(Specificity and Prediction Accuracy up to 100%) Our artificial intelligence deep learning service model has sufficient scalability and can be extended to other diseases, such as viral infectious diseases (such as SARS-related coronavirus and HIV), and degenerative diseases (such as cardiovascular disease), Osteoarthritis, Alzheimer, etc.), and metabolic diseases (such as diabetes, etc.). This model quantifies the interaction between genotypes and phenotypes so that the interaction between genes can be seen, diseases’ pathogenesis and causes can be known, risks assessment can be made, drug responses and resistance can be known for treatment strategy and recommendations (both Chinese and Western medicine).

1 to 10 staff

Beauty- Natural Ingredients Supplier

is the global leader and supplier of premium microalgae ingredients, coloring pigments, and flavorings for the pharmaceutical, nutraceutical, cosmetics, aquaculture, e-cigarette and food and beverage industries. Advantage: meters of indoor, state-of-of -the art,GMP+compliant cultivation. High astaxanthin content in the dried algal biomass(up to 8%). Completely sealed microalgae cultivation system, to eliminate any contamination.Zero traces of heavy. Proprietary SPD spectrum technology, enabling 70% reduction in energy use, yet improving production yield by 200%. Reverse osmosis water is used for production eliminating any impurities in the culture medium Cultivation process paraments of microalgae is strictly controlled to produce the best quality in mass volume. 24*7 fully computerized photobioreactor system, enabling comprehensive analysis and monitoring of production parameters through the whole cultivation process. Key products include: AstaKING(astaxanthin powder & oleoresin; astaxanthin CWS powder) for Nutrition and supplement, AstaFEED (H.Pluvialis cracked powder) for natural feed additives. JustAlga (Fucoxanthin,Euglena,Chlorella)

1 to 10 staff

Lucy Biotech

1 to 10 staff

Prenetics

Prenetics (NASDAQ: PRE) is redefining health and longevity through IM8, its flagship consumer healthcare brand co-founded with David Beckham, represented by World No. 1 tennis champion Aryna Sabalenka, and an elite team of scientists spanning medicine, academia and space science. In just 12 months, IM8 reached $120M in ARR, becoming the fastest growing supplement brand in history, even outpacing today's leading AI startups.

51 to 200 staff

Ck Life Sciences

CK Life Sciences Int’l,(Holdings) Inc.(stock code: 0775) is listed on the Stock Exchange of Hong Kong. Bearing the mission of improving the quality of life, CK Life Sciences is engaged in the business of research and development, manufacturing, commercialisation, marketing, sale of, and investment in, products and assets which fall into three core categories - nutraceuticals, pharmaceuticals and agriculture-related. CK Life Sciences is a member of the CK Hutchison Group.

51 to 200 staff

Diagcor Bioscience Incorporation Limited

DiagCor, Hong Kong’s leading MDx innovator, is guided and operated by a respected group of biotech scientists and executives with an extraordinary depth and breadth of experience. We are perceived by our customers to be dedicated, responsive and caring, which are the core values we wish to uphold. We manufacture advanced in-vitro diagnostic products and provide clinical diagnostic services.

51 to 200 staff

Bio-Gene Technology

Since its establishment in 1993, Bio-Gene Technology Limited (Bio-Gene) has been providing top-quality solutions to scientific laboratory markets in Hong Kong, Macau and Mainland China. We are the authorized distributor for world-renowned and innovative suppliers of instruments, reagents and consumables for analytical sciences, clinical diagnostics, food and pharmaceutical safety, life sciences and laboratory setup services. We provide professional pre- and post-sales services and work hand-in-hand with our customers from problem profiling to solution implementation. We are committed to surpassing our customers’ expectations by providing the best products and services through our offices and subsidiaries in Hong Kong and Mainland China- To Satisfy Today’s & Tomorrow’s Needs of Customers- To Help Products to Find Right Customers. Professionalism, Focus, Passion, Partnership, Credibility, Customer Satisfaction.

11 to 50 staff

Gutolution

Company: GUTolution is a microbiome biotechnology company aiming to empower human healthspan beyond 120 years old. It specializes in at-home diagnostic, precision nutrition, personalized healthtech and health-intelligence-as-a-service (“HIaaS”), powered by translational medicine, next-generation sequencing, artificial intelligence and blockchain technology. Product: GUTolution’s 1st product is a revolutionary AI-powered at-home precision microbiome health solution for reversing chronic diseases at low cost, combining at-home health tests, personalized diet and lifestyle recommendations, GMP-standard personalized custom probiotics, and mobile-based virtual coaching. Awards/ Events/ Funding/ Partnership HKSTP Incubation Programme, Dec 2023, https://bit.ly/3QFVHen HK Tech 300, Angel Fund Team (7th Cohort), July 2023, https://bit.ly/3oMzzD4 HK AI Lab (9th Cohort), June 2023, https://hongkongai.org/portfolio/ Global Top 100, JUMPSTARTER 2023, June 2023, New Potential Start-up, HKUST Unicorn Day 2023, May 2023, https://bit.ly/46aRPHu Highlighted Start-up, Asia Global Summit 2023, May 2023 https://bit.ly/3OueLLf Featured Speaker (Wayne Chan, CEO), BIOHK Conference 2022, Dec 2022 https://bit.ly/42PmvLm Finalist & Top 9, HKUST-Sino One-million-dollar Entrepreneur Competition https://bit.ly/3pvEWHt Finalist & Top 10, Hong Kong Techathlon 2022, Jan 2022 Media Coverage/ Featured Interviews: Instagram: Website: https://gutolution.com/ ST Headline on 11 May 2023: https://bit.ly/45jO9CM HKTDC on 16 Apr 2023: https://hkmb.hktdc.com/tc/N14XOIfv #LogevityBiotechinology #PrecisionNutrition #AtHomeDignostic #VirtualCoaching #HIaaS #AI #NextGenerationSequencing #Microbiome #Neuroscience #MobileApps #Web3 #Metaverse

1 to 10 staff

Govita Tech Limited

Govita is an advanced biotechnology company providing personalized health solutions based on molecular testing, AI algorithms and nutraceuticals. Govita is committed to serving clinical practitioners and the public with validated methods and products with rigorous scientific standards. We also participate in research studies using our proven personalized health solutions to validate the effectiveness of TCM and Western medicine interventional products and build large databases. Our future goal is to continue to develop and optimize our personalized health solutions for successful integration into digital medicine for practical and widespread applications in the R&D and industry to extend healthy lifespan.

11 to 50 staff

Hong Kong Genome Institute

The Hong Kong Genome Institute (HKGI), established and wholly owned by the Hong Kong SAR Government, commenced full operations in 2021. With the vision “to avail genomic medicine to all for better health and well-being” and supported by the Health Bureau, HKGI works in close collaboration with the Department of Health, Hospital Authority, medical schools of local universities and other stakeholders to accelerate the development of genomic medicine in Hong Kong along four strategic foci: integrate genomics into medicine, advance research, nurture talents, and enhance public genomic literacy and industry partnership | enquiry@genomics.org.hk

51 to 200 staff

The Hong Kong Institute Of Biotechnology Limited

The Hong Kong Institute of Biotechnology Limited (HKIB) was established by the Council of the Chinese University of Hong Kong (CUHK) in 1988 with a donation from the Hong Kong Jockey Club Charities Trust. Our mission is to provide catalyst and essential infrastructure for the development of biotechnology and Chinese medicine (CM) industries in Hong Kong. Throughout the years, we have received grants from the Innovation & Technology Commission (ITC) to advance our capacity in research and GMP production in these two areas. HKIB provides extensive services on infrastructure support, product & technology development, contract manufacturing, Good Manufacturing Practice (GMP) consultation and training. With our expertise, we actively engage in process development, product commercialization as well as collaborative projects with industrial partners for fund application in bringing new technology and product development in biotechnology, pharmaceuticals and CM. Being affiliated with CUHK and a designated local public research institute of the ITC, HKIB enjoys the benefits of being the focal point of collaboration among academia, government and industry to promote biotechnology and CM in Hong Kong. As a not-for-profit organization, the services are provided on a cost-recovery and pay-per-use basis. We can be your strategic partner in transforming research results into viable commercial products.

51 to 200 staff

Vitargent International Biotechnology Limited

Established in 2010, Vitargent (International) Biotechnology Limited has a vision of "Smarter Testing, Safer Products, Better World". We develop bio-testing technologies that include transgenic medaka and zebrafish embryo toxicity testing technologies. In 2013, Vitargent was accredited for the international standard ISO17025 and became the only test centre in Asia that can provide fish embryo toxicity (FET) testing with results officially recognised in more than 100 countries and economies. We are the proud winner of the Grand Prix at the International Exhibition of Inventions of Geneva (2015). 2015 Davos Global Innovation Pioneer, HSBC Young Entrepreneur Award, Second Runner-up of Lee Kuan Yew Global Business Plan Competition, Middle East International Invention Fair Gold Medal, WIPO Gold Medal for Inventors, Korea International Invention Exhibition-Gold Award and Hong Kong Awards for Industries-Technological Achievement Award. Based in Hong Kong with licensed laboratories in Europe and Taiwan, serving top-notch testing organisations, governments, major international cosmetics companies and catering groups around the world. Learn more at

11 to 50 staff

Biomed Technology Holdings Limited

Founded by a group of specialist/professors, biomedical scientists and medical doctors, we provide one-stop service, including a series of high-tech and professional tests with interpretation and suggested solutions to achieve a healthy life.

11 to 50 staff

Geneditbio Limited

Established in 2021 and headquartered in Hong Kong, China, GenEditBio is a gene therapy start-up company with an overarching strategic goal of providing potentially curative, once-and-done and programmable in vivo genome editing-based therapeutic solutions (dubbed “DNA surgery”) with high safety profile, unmatched precision, and affordable access for genetic diseases with unmet needs. The Company’s core areas of focus include novel Cas nuclease discovery and safe and efficient cargo delivery utilizing lipid nanoparticle (LNP) and engineered protein delivery vehicle (PDV). We have research laboratories and supporting offices in Hong Kong, Beijing, and Boston.

51 to 200 staff

Centre For Translational Stem Cell Biology Ctscb

The Centre for Translational Stem Cell Biology (CTSCB) aims to develop world-leading technologies in Hong Kong and apply them to regenerative medicine, autoimmunity, and genomic medicine during this golden age of research. We bring together top scientists and clinicians specialising in stem cells and genomics from Hong Kong, the UK, and around the globe. We strive to translate their discoveries into both commercial success and healthcare innovations. At CTSCB, we utilise the state-of-the-art technology known as Expanded Potential Stem Cells (EPSC). This technology was initially developed in Professor Pengtao Liu's laboratory at the Wellcome Trust Sanger Institute in collaboration with the University of Cambridge and, more recently, at The University of Hong Kong. Under the leadership of this group of elite scientists and clinicians, we aim to innovate clinical, translational, and fundamental research through three interconnected research programs: New Stem Cell Technology, EPSCs for Human Disease and Regenerative Medicine, and EPSCs for Genomic Medicine of Immune Disease.

51 to 200 staff

Cordlife Hong Kong Limited

Listed on the Main Board of Singapore Exchange (SGX), Cordlife Group Limited was established to provide a full suite of cord blood and tissue banking services which include the collection, processing and cryopreservation storage of cord blood stem cells and umbilical cord tissue. Since its inception in 2001, our Group has grown rapidly from a fledging start-up company in Singapore into a multi-national corporation. Expertise and quality you can trust Our Group’s in-depth knowledge of cord blood banking practices and standards has developed strong capabilities to attain many accreditations and certifications from many quality standard organizations such as the American Association of Blood Banks (AABB), the International Organization for Standardization (ISO) and Ministry of Health, Singapore. As a further testament of our quality and standard, we are proud to be appointed as the Quality Advisor to Beijing Cord Blood Bank, the first of its kind in the industry. Our footprint in Asia Today, CordLife Group Limited has established state-of-the-art cord blood processing and tissue storage facilities in Singapore, Hong Kong and Mainland China with a network extended to India, Indonesia and the Philippines.

51 to 200 staff

Epimedtech Global

HKG Epitherapeutics Ltd. was founded in 2016 by Prof. Moshe Szyf, a leading world pioneer in the exciting and rapidly emerging science of Epigenetics. We are dedicated to harnessing the untapped power and possibilities of Epigenetics, with the research and diagnostic lab in Hong Kong, and planning to expand operations by establishing “next generation” genetic diagnostic labs in several countries.

11 to 50 staff

Eurofins Modern Genomic Services Limited

As an HKSAR Government recognized testing institution, MGS can provide Health Declaration Forms for international travel. We provide a convenient one-stop solution package including a doctor’s consultation, fit-to-fly certificates and courier service, so our customers can utilize our testing services from the comfort of your own home.

11 to 50 staff

Medikonia

Based in Hong Kong, Medikonia is a leading solution provider in biological products and medical devices. We are committed to making research simply easier by offering innovative and superior value solutions to scientists. Delivering the highest quality products and providing responsive support is in our company DNA. Medikonia is led, guided and operated by a group of professionals with strong scientific background. We collaborate with distinctive and excellent brands and experts worldwide spanning a wide range of biological fields and applications. Our product portfolio covers reagents, cell culture solutions, kits, devices and equipment.

11 to 50 staff

Pointfit Technology

At PointFit, we're revolutionizing health monitoring with our cutting-edge skin patch technology. Our wearable devices transform sweat analysis into accessible, continuous insights previously limited to labs and hospitals. Experience the future of health monitoring—seamless, non-invasive, and right at your fingertips.

1 to 10 staff

Take2 Health

TAKE2 is a healthcare start-up which explores, invents, and builds empowering platforms to harness the power of biomedical sciences and informatics to deliver better healthcare solutions to individuals and communities with actionable information and results. Headquartered in Hong Kong, China, TAKE2 aims to be a key driver that makes the most disruptive healthcare inventions widely accessible to the public in China and Asia.

11 to 50 staff

Xellera Therapeutics

Founded in 2018, Xellera operates Hong Kong’s FIRST commercial cGMP facilities for clinical-grade cell and gene therapy (CGT) products in the region approved using the PIC/s guidance. Specific for the complex manufacturing process of Advanced Therapy Medicinal Products (ATMP).#Biotechnology #Biomedicine #Precision Medicine #Regenerative Medicine #Cell-based Therapies #Gene-based Therapies

11 to 50 staff

Greentins Group Limited

Established in 2005, Greentins is a pioneering innovator in the environmental protection industry of Hong Kong, specializing in the research, development and innovation of environmentally friendly solutions and products. Over the years, Greentins® has earned a reputation that has a unique combination of quality, trust, value and reliability. With our vision of building a cleaner, more sustainable future, Greentins' mission is to create affordable, serene and healthy spaces in today's high-density urban environments that will continue to enhance the quality of life into the future.

11 to 50 staff

Smartlab Hub Smlh

SmartLab Hub is an intelligent platform for laboratory supplies around the world! You will find smarter choices with SmartLab Hub that can help improve the productivity and reliability of your laboratory process. Enjoy our world-wide product availability, fast delivery, competitive delivery cost, and effortless customs clearance in the continent of Asia in a strategic logistic location with excellent international infrastructure. With over 30 years of experience in high quality scientific equipment and laboratory suppliers, our professional business and operation teams will provide both quality products and services that will give you satisfaction like no other. No matter you are laboratory users or management, laboratory supplies agents or dealers, or manufacturing suppliers, you will find the values of Smartlab Hub. Connect to SmartLab Hub - enjoy the powerful hub services to smarten up the lab easier and faster. Connect@SmartLabHub.com Backing up by our logistic hubs in a strategic location of Asia, we have excellent international infrastructure to have fast delivery, competitive delivery cost and less complicated customs clearance for Asia customers. We are a company with 30+ years of presence in high quality scientific equipment and laboratory suppliers. We know what you need no matter who you are as end users, or dealers or suppliers. Our professional business and operation teams will bring you not just quality products with good price performance, but also professional services with good satisfaction experience. Connect to SmartLab Hub to enjoy the powerful hub services to smarten up the lab easier and faster.

51 to 200 staff

Xcelom Limited

Xcelom has been exclusive licensed by CUHK to provide an Non-Invasive Prenatal Technology (NIPT) service called "safeT21express". safeT21express is a test that analyses such circulating cell-free DNA molecules with next-generation DNA sequencing technologies, and performs bioinformatics analysis. Genetic information from the unborn child can be obtained, which could include the screening results for- Down syndrome (T21)- Edwards syndrome (T18)- Patau syndrome (T13)- Sex chromosome aneuploidies: 45, X0 (Turner syndrome)- Sex chromosome aneuploidies: 47, XXY (Klinefelter syndrome)- Sex chromosome aneuploidies: 47, (Triple X)- Sex chromosome aneuploidies: 47, XYY (Jacob syndrome)- Microdeletions analysis related to 1p36 deletion syndrome - Microdeletions analysis related to 2q33.1 deletion syndrome - Microdeletions analysis related to Angelman syndrome - Microdeletions analysis related to Cri-du-Chat syndrome - Microdeletions analysis related to 22q11 deletion syndrome (include DiGeorge syndrome)- Microdeletions analysis related to Langer-Giedion syndrome - Microdeletions analysis related to Prader-Willi syndrome Looking ahead, Xcelom will continue to use Hong Kong as its base to market its NIPT solution to Asia and the rest of the world.

51 to 200 staff

Inomixo

INOMIXO is an innovative company dedicated to providing multi-omics solutions in the field of life sciences. By integrating AI big data with advanced mass spectrometry platforms, along with our team’s experienced R&D expertise, INOMIXO has developed two primary business segments: academic omics services and biopharmaceutical CRO services. We offer proteomics, peptidomics, metabolomics, spatial omics, and bioinformatics analysis to academic organizations. Additionally, we provide customized CRO and CMC certification services for the biopharmaceutical industry. We commit to creating a business landscape that delivers robust, professional, and cutting-edge omics solutions for advancing life sciences.

1 to 10 staff

Invitrocue Hk Limited

Invitrocue was first founded in 2012 to commercialize proprietary 3D cell culture technology developed at A*STAR’s Institute of Bioengineering and Nanotechnology in Singapore, Massachusetts Institute of Technology Cambridge, and the Genome Institute of Singapore. These technologies and know how have since been successfully developed into commercial services such as in vitro Human Liver models for drug toxicology testing, in vitro Human NASH (Fatty Liver) model, in vitro Human Liver Infection models, in vitro Human Respiratory models, in vitro Human Oncology Organoids and in vivo Humanized Immune Organoid. These technologies are a key advancement in supporting the treatment in a range of cancers with leading global Cancer centers and leading pharmaceutical companies in their drug development programs. Invitrocue is headquartered in Singapore, with operations in Germany, Spain, Brazil, Australia, China and Hong Kong.

11 to 50 staff